October 4-6, 2020 Virtual Conference
![]() |
![]() |
![]() |
![]() |
POSBAS-001 | A grafted co-polymer based Nanomicelles aided topical ocular delivery for treating posterior uveitis. | Nikita . | ![]() |
![]() |
|||
POSCAT-001 | Natural products as prospective alternative treatments for neurodegenerative disease | Sunisha Aryal | ![]() |
![]() |
|||
PSWCS-001 | Opportunities, Barriers, and a Strategy for Overcoming Translational Challenges to Therapeutic Nucleic Acid Nan otechnology | Kirill Afonin | ![]() |
![]() |
|||
POSDSI-001 | Relationships between serum nivolumab and peripheral blood lymphocyte, serum IgG, or cachexia stage in cancer patients | Kazuki Abe | ![]() |
![]() |
|||
POSANC-001 | Blockade of immunosuppression boosts HLA allele-specific idiosyncratic drug toxicity by abacavir in the HLA-transgenic mice | Shigeki Aoki | ![]() |
![]() |
|||
POSEMT-002 | Observations of Nursing Practices Related to Drug Preparation and Administration in Care Units: a cross-sectional study | Jean-Franois Bussières | ![]() |
![]() |
|||
POSCAT-002 | Evaluation of Doravirine Pharmacokinetics in Pregnant Women using Physiologically-Based Pharmacokinetic Models | Shakir Adeyinka Atoyebi | ![]() |
![]() |
|||
POSDSI-002 | Socioeconomic factors influencing antibiotic misuse in patients visiting the general outpatient department, Ahmadu Bello University teaching Hospital, Zaria | Adejoke Adelaja | ![]() |
![]() |
|||
POSBAS-002 | Synthesis and characterization of a Metal-Organic Framework (MOF) as a topical delivery system of Sulfadiazine for wound prophylaxis. | Javier Aguila-Rosas | ![]() |
![]() |
|||
PSWCS-002 | Evolutionary Therapy for Metastatic Cancer | Alexander Anderson | ![]() |
![]() |
|||
POSANC-003 | Dissolving Polymeric Microneedles for the Delivery of Sensors for Real-Time Physiological Monitoring | Samuel Babity | ![]() |
![]() |
|||
POSCAT-003 | Dynamical Systems Analysis as an Additional Tool to Improve Immuno-oncology Treatments | Aymen Balti | ![]() |
![]() |
|||
POSEMT-003 | Descriptive Pilot Study of Healthcare Workers Exposure to Cyclophosphamide, Ifosfamide, Methotrexate and Fluorouracil by 24-Hour Urine Assay | Jean-Franois Bussières | ![]() |
![]() |
|||
POSEMT-004 | Role and impact of pharmacist in Belgium: a scoping review | Jean-Franois Bussières | ![]() |
![]() |
|||
PSWCS-004 | Linking otic quinolone and tympanic membrane perforations: Validating pharmacoepidemiologic safety signals with laboratory models | Patrick Antonelli | ![]() |
![]() |
|||
POSDSI-004 | Adverse events of SGLT2 inhibitors associated with Health Canada safety warnings: An overview of quantitative systematic reviews. | Wajd Alkabbani | ![]() |
![]() |
|||
POSEMT-005 | Design of next-generation peritoneal dialysis fluids for the treatment of Alzheimers Disease | Philippe Delbreil | ![]() |
![]() |
|||
POSBAS-005 | DEVELOPMENT AND OPTIMIZATION OF ARTEETHER LOADED NOVEL DRUG DELIVERY SYSTEM USING FORMULATION BY DESIGN CONCEPT FOR INTENSIFIED ORAL BIOAVAILABILITY | Neha Bajwa | ![]() |
![]() |
|||
POSCAT-005 | CANDESARTAN CILEXETIL TWO STEP IN VITRO-IN VIVO CORRELATION (IVIVC) | Marival Bermejo Sanz | ![]() |
![]() |
|||
POSDSI-005 | Emerging roles for Pharmacists in Mental health care: Assessing mental health literacy among Pharmacists in Nigeria | Deborah Aluh | ![]() |
![]() |
|||
POSEMT-006 | Detection of adverse drug reactions from the coding of episodes of care by medical archivists | Amelie Duhamel | ![]() |
![]() |
|||
POSCAT-006 | Expansion of a Levonorgestrel Physiologically-Based Pharmacokinetic Model (PBPK) to Evaluate the Pharmacokinetic/Pharmacodynamic (PKPD) Effects of SHBG Protein Binding | Brian Cicali | ![]() |
![]() |
|||
POSANC-006 | Identification of a novel inhibitor for hepatitis B virus internalization targeting viral receptor oligomerization | Kento Fukano | ![]() |
![]() |
|||
PSWCS-006 | Developing long lasting oral drug delivery systems for infectious disease | Jessica Ballinger | ![]() |
![]() |
|||
POSANC-007 | Effect of co-administration of warfarin and prednisolone on anticoagulant therapy and its possible mechanism in relation to the Niemann-Pick C1-like 1-mediated pathway | Sayo M Ito | ![]() |
![]() |
|||
POSDSI-007 | Torsades de pointes: Should we really fear psychotropic drugs? | Samuel Cyr | ![]() |
![]() |
|||
POSBAS-007 | Administration of ive CD36 (SR-B2) receptor ligands by dissolving microneedle arrays for the treatment of atherosclerosis | Cloe Esposito | ![]() |
![]() |
|||
POSCAT-007 | THE EFFECTS OF CITICOLINE IN CHRONIC ISCHEMIA INDUCED BY MOVEMENT RESTRICTION | Tatevik Grigoryan | ![]() |
![]() |
|||
POSEMT-007 | Evaluation of the rate of compliance with good pharmacovigilance reporting practices 12 months after their adoption | Amelie Duhamel | ![]() |
![]() |
|||
POSDSI-008 | PHARMACEUTICAL ACTIVITIES IN THE NEONATAL INTENSIVE CARE UNIT: AN INTEGRATIVE LITERATURE REVIEW | Marta Maria Fonteles | ![]() |
![]() |
|||
POSANC-008 | Flucloxacillin induces liver injury in mice pretreated with a toll-like receptor 9 agonist in mitochondrial permeability transition dependent manner | Yuying Gao | ![]() |
![]() |
|||
POSCAT-008 | DYNAMICS OF MATERNAL MORTALITY IN TWO TERTIARY HOSPITALS IN SOUTHEAST NIGERIA: SAVING THE LIVING FROM THE DEAD | Michael Iweh | ![]() |
![]() |
|||
POSBAS-008 | Surface properties of PLA-PEG Nanovectors modulates their interactions with brain endothelial cells: inflammatory response versus transcytosis efficiency | Soudeh F.Tehrani | ![]() |
![]() |
|||
POSEMT-008 | Insilico Modelling of the thiophene analogues as a PTP1B inhibitors | Sunil Kuamr Dwivedi | ![]() |
![]() |
|||
PSWCS-009 | Global omics approach for the development of nanomedicines in cancer; overcoming drug resistance and increasing ivity | Erem Bilensoy | ![]() |
![]() |
|||
POSCAT-009 | Plasma concentration changes of endogenous OATP1B1 substrates before and after paclitaxel administration in non-small cell lung cancer | Hiroyuki Kusuhara | ![]() |
![]() |
|||
POSEMT-009 | IMPLEMENTATION OF MEDICATION REVIEW TO OUTPATIENTS WITH RHEUMATOID ARTHRITIS IN TEACHING HOSPITAL | Marta Maria Fonteles | ![]() |
![]() |
|||
POSDSI-009 | The Future of Pharmacogenomics application in Alberta Community Pharmacies | Dalia Hamdy | ![]() |
![]() |
|||
POSANC-009 | Repurposing Angiotensin-Converting Enzyme inhibitors for the treatment of Alzheimers disease: Lessons from a Drosophila model | Patricia Jumbo | ![]() |
![]() |
|||
POSCAT-010 | Investigation of intronic polymorphisms and transcription factors responsible for the OCT2 expression | Hiroyuki Kusuhara | ![]() |
![]() |
|||
PSWCS-010 | A multi-disciplinary collaboration using pharmacometrics, pharmacoepidemiology, and pharmacoeconomics for efficacy and safety questions related to generic substitution | Joshua Brown | ![]() |
![]() |
|||
PSWCS-011 | The Role of microbes in drug responses New models | Filipe Cabreiro | ![]() |
![]() |
|||
POSBAS-011 | Specific recognition for target cells using Fab-PLGA/siRNA-PLGA mixed micelles | Mai Hazekawa | ![]() |
![]() |
|||
POSDSI-011 | Feasibility study of drug quantification in breast milk by liquid chromatography coupled to mass spectrometry (LC-MS/MS) | Analle Monfort | ![]() |
![]() |
|||
POSEMT-011 | Implementation of Pharmacogenomics in Community Pharmacies in Alberta: Perceptions and Challenges | Dalia Hamdy | ![]() |
![]() |
|||
POSANC-012 | Pattern of Antibiotics use at the Department of Surgery, Korle-Bu Teaching Hospital | Josephine Mensah | ![]() |
![]() |
|||
POSEMT-012 | Analysis of long-term progression of Parkinsons disease by SReFT (Statistical Restoration of Fragmented Time-course) suggested slower progress in patients with LRRK2 G2019S mutation | Akihiro Hisaka | ![]() |
![]() |
|||
PSWCS-012 | Targeted Degradation of BTK: a PROTAC case study | Matthew Calabrese | ![]() |
![]() |
|||
POSBAS-012 | Polymer-lipid interplay in altering liquid-liquid phase separation and supersaturation evolution of poorly soluble drugs | Jiahao Huang | ![]() |
![]() |
|||
POSCAT-012 | First-in-Human Studies of Monoclonal Antibodies in Oncology: An Overview of Study Designs and Stopping Criteria | Man Qing Liang | ![]() |
![]() |
|||
POSDSI-012 | Evaluation of intranasal drug delivery devices in its design and usability | Mikio Murata | ![]() |
![]() |
|||
POSBAS-013 | L-serine-modified polyamidoamine dendrimer as a highly potent renal targeting drug carrier | Hidemasa Katsumi | ![]() |
![]() |
|||
POSEMT-013 | An Assessment of Safety Culture in Saskatchewan Community Pharmacy Practice in Canada | Certina Ho | ![]() |
![]() |
|||
PSWCS-013 | Pharmaceutical science degree accreditation - the APS model | William Dawson | ![]() |
![]() |
|||
POSDSI-013 | Impact of ISO17025 Laboratory Accreditation in sub-Saharan Africa: A case study | Mercy OKEZUE | ![]() |
![]() |
|||
POSCAT-013 | Investigation of fluorescent substrates of a drug transporter organic anion transporting polypeptide 2B1 | Tomohiro NABEKURA | ![]() |
![]() |
|||
POSANC-014 | Relationship between genotype and/or phage ORF type of ESBL-producing Escherichia coli and fluoroquinolones resistance | Nobuhiro Nishimura | ![]() |
![]() |
|||
POSCAT-014 | Substrate-dependent interactions of organic anion transporting polypeptide 2B1 with natural compounds | Tomohiro NABEKURA | ![]() |
![]() |
|||
PSWCS-014 | Training drug hunters - integrating clinical development into a pharmaceutical science degree | Denis deBlois | ![]() |
![]() |
|||
POSEMT-014 | Residents Perception of One-Year Industrial Pharmacy Residency Program in Canada | Certina Ho | ![]() |
![]() |
|||
POSBAS-014 | Aspartic acid modified dendrimer-based micelle as a highly potent bone resorption surface-targeting nano-carrier for the efficient treatment of bone metastasis | Hidemasa Katsumi | ![]() |
![]() |
|||
POSDSI-014 | Validation of an algorithm to predict advanced chronic kidney disease from linked health insurance administrative databases in Quebec | Sylvie Perreault | ![]() |
![]() |
|||
POSDSI-015 | Predicting Major Bleeding among Real-World Oral Anticoagulant Users with Atrial Fibrillation | Jakub Qazi | ![]() |
![]() |
|||
POSCAT-015 | Mechanistic study of endocrine disruptors induced fetal toxicity: A computational insight | Kalyan Venkata | ![]() |
![]() |
|||
POSBAS-015 | TRIPLE COMBINATION OF HERBAL BIOACTIVE MOLECULES LOADED NANOEMULGEL AS A TOPICAL DRUG DELIVERY TO COMBAT ACNE VULGARIS | Karishma khatoon | ![]() |
![]() |
|||
POSBAS-016 | Formulation and evaluation of a solid self-emulsifying drug delivery system using an oily liquid model compound | You Zhuan Lee | ![]() |
![]() |
|||
POSEMT-016 | Compound Selection assisted by Bayesian Inference of Efficacy Metrics | Caroline Labelle | ![]() |
![]() |
|||
PSWCS-016 | Microdialysis as a tool to monitor local exposure of anti-infective agents | Hartmut Derendorf | ![]() |
![]() |
|||
POSCAT-016 | Optimizing Cytotoxic Chemotherapy regimens in the Context of Triple Negative Breast Cancer | Rosalba Vivian Paredes Bonilla | ![]() |
![]() |
|||
POSCAT-017 | A Bioanalytical Methodology And Pharmacokinetic Evaluation Of Amphotericin B In Healthy And Infected Wistar Rats | Jackeline Marley de Araújo | ![]() |
![]() |
|||
POSDSI-017 | Impact of CYP2D6 activity on enantiomeric pharmacokinetics of tramadol and its demethylated metabolites in patients with head and neck cancer | Koji Suzuki | ![]() |
![]() |
|||
POSANC-017 | In silico structural analysis of HLA complexes associated with idiosyncratic drug toxicities | Tomohiro SHIRAYANAGI | ![]() |
![]() |
|||
PSWCS-017 | How to support healthcare professionals with scientific evaluation of medication errors and, regulatory authorities with medication errors guidance evaluation | Brian Edwards | ![]() |
![]() |
|||
POSCAT-018 | The Increasing Challenge of Levodopa Dosing in Parkinson with Disease Progression: Modeling Insights | Florence Véronneau-Veilleux | ![]() |
![]() |
|||
POSANC-018 | Pharmacometrics of equivalence for the treatment of ADHD with methylphenidate | Sara Soufsaf | ![]() |
![]() |
|||
POSBAS-019 | Transcutol: A promising drug solubilizer suitable for in continuous flow liposome production in a Periodic Disturbance mixer. | Ruben Lopez | ![]() |
![]() |
|||
POSANC-019 | Ezetimibe-mediated prevention and recovery of hepatic NPC1L1-dependent dietary steatosis in mice. | Tappei Takada | ![]() |
![]() |
|||
POSDSI-019 | Assessment of knowledge, attitude and practice of self- medication among undergraduate medical and paramedical students of Gandaki Medical College, Nepal | Bindu Malla | ![]() |
![]() |
|||
PSWCS-019 | Successes and challenges of fecal microbiota transplantation for treating recurrent Clostridioides Difficile | Hala Fadda | ![]() |
![]() |
|||
POSEMT-019 | Outcomes from efforts at advancing capacity for manufacturing quality medicines in sub-Saharan Africa - the BIRS program | Mercy OKEZUE | ![]() |
![]() |
|||
POSCAT-019 | In Vitro Release Study of Drug-loaded Polymeric Nanoparticles: Using The Appropriate Method | Jingwen Weng | ![]() |
![]() |
|||
PSWCS-020 | Toward the efficient discovery of actionable chemical matter from DNA-encoded libraries | Timothy Foley | ![]() |
![]() |
|||
POSDSI-020 | Evaluation of Press Through Package(PTP) with the function of Child Resistance and Senior Friendly(CRSF) | Kiyomi Sadamoto | ![]() |
![]() |
|||
POSANC-020 | ABCG2 is a physiological exporter of indoxyl sulfate, and its dysfunction accelerates the progression of chronic kidney disease. | Takehito Yamamoto | ![]() |
![]() |
|||
POSANC-021 | ATP Metabolism in the Red Blood Cells as Potential Surrogate Biomarker and TherapeuticTarget for Post-Exercise Hypotension and Cardiovascular Protection | Pollen Yeung | ![]() |
![]() |
|||
POSEMT-021 | International Standards for Quality Management Systems of Pharmaceutical laboratories; disparities versus similarities | Mercy OKEZUE | ![]() |
![]() |
|||
PSWCS-021 | Importance of last-mile delivery of drugs and their rational use by end-users for improved health outcomes | Patrick Gaparayi | ![]() |
![]() |
|||
PSWCS-022 | Artificial in vitro biosynthesis for backbone-modified peptides | Yuki Goto | ![]() |
![]() |
|||
PSWCS-023 | Overview of 3D printing technologies in pharmaceutical sciences | Alvaro Goyanes | ![]() |
![]() |
|||
POSBAS-023 | Investigation of transdermal formulations for improved delivery of phytocannabinoids | Chulhun Park | ![]() |
![]() |
|||
POSBAS-024 | Rapid Dissolving Capsules for the Administration of Gastric-resistant Prednisolone Microparticles for Paediatric and Geriatric Patients | Kavil Patel | ![]() |
![]() |
|||
PSWCS-024 | HTS in a non-profit environment: The EU perspective | Sheraz Gul | ![]() |
![]() |
|||
POSEMT-024 | Deployment of a Web-based Tool Built from Pharmacy Claims Data to Monitor Adherence to Respiratory Medications in Primary Care: A Feasibility Study | Alia Yousif | ![]() |
![]() |
|||
POSBAS-025 | Sustained Release Fixed Dose Combination Products in Microparticle-Filled Straw developed using the MicroCoatTM technology | Kavil Patel | ![]() |
![]() |
|||
POSEMT-025 | PHARMACEUTICAL INTERVENTIONS AS A TOOL TO REDUCE EMOTIONAL STRESS AND LOW ADHERENCE TO TREATMENT IN PEOPLE WITH DIABETES IN PRIMARY CARE | Reijane Mara Pinheiro Queiroz | ![]() |
![]() |
|||
PSWCS-026 | Engineering Delivery Systems for Global Health | Ana Jaklenec | ![]() |
![]() |
|||
POSBAS-026 | Instant Jellies as a Potential Delivery Vehicle for the Administration of Sustained Release Microparticles to Improve Palatability of Paediatric and Geriatric Medicines | Kavil Patel | ![]() |
![]() |
|||
PSWCS-027 | 3D printing in pharmaceutical sciences - intellectual property aspects | Catherine Jewell | ![]() |
![]() |
|||
PSWCS-028 | The use of microdialysis in translational drug development | Francine Johansson Azeredo | ![]() |
![]() |
|||
PSWCS-029 | Challenges to Therapeutic Repurposing and Development in a Pandemic. | Steven Kern | ![]() |
![]() |
|||
POSBAS-029 | Novel 3D printed capsule with integrated magnetic field triggerable anti-cancer drug delivery system | Kejing Shi | ![]() |
![]() |
|||
PSWCS-030 | Ceramide Nanoliposomes: the Road to the Clinic | Mark Kester | ![]() |
![]() |
|||
POSBAS-031 | Preparation of clozapine-loaded PLGA nanoparticles for nose-to-brain delivery using supercritical fluid technology | Madeleine Tan | ![]() |
![]() |
|||
POSBAS-032 | Exosomes and Outer membrane Vesicles: In-vivo analysis of Drug Delivery Nanotools | Shindu Thomas | ![]() |
![]() |
|||
PSWCS-032 | Microdialysis to monitor target site concentrations of large molecules | Vipada Khaowroongrueng | ![]() |
![]() |
|||
PSWCS-033 | Design of oral drugs beyond the rule of 5 Opportunities, some guidelines and challenges | Jan Kihlberg | ![]() |
![]() |
|||
POSBAS-033 | BUDESONIDE LOADED COLON TARGETED NANOFIBER DRUG DELIVERY SYSTEM | YAS&304;N TURANLI | ![]() |
![]() |
|||
POSBAS-035 | Effects of Labrasol and its related formulations on the intestinal absorption of insulin and elucidation of their absorption enhancing mechanisms | Hiroki Ukai | ![]() |
![]() |
|||
POSBAS-036 | Development and Evaluation of Cholecalciferol-loaded PEGylated Nanoparticles for Brain Drug Delivery: Effect of Particle Size | Jingwen Weng | ![]() |
![]() |
|||
PSWCS-036 | Translating research into practice: Pharmacists roles to support antimicrobial stewardship -a focus on low-and middle-income countries | Eneyi Kpokiri | ![]() |
![]() |
|||
PSWCS-037 | New approaches to tackle antimicrobial resistance : antimicrobials and beyond | Teruo Kuroda | ![]() |
![]() |
|||
POSBAS-038 | Evaluating population pharmacokinetic modelling methods to guide individualized dosing when switching to extended half-life products in hemophilia A patients | Jacky Yu | ![]() |
![]() |
|||
PSWCS-038 | Pharmacokinetic PET imaging in drug research | Oliver Langer | ![]() |
![]() |
|||
PSWCS-039 | Novel Drug Delivery Approaches for Global Health: Challenges & Opportunities | Dennis Lee | ![]() |
![]() |
|||
PSWCS-040 | Translating from benchside to bedside | Nathalie Letarte | ![]() |
![]() |
|||
POSBAS-040 | Evaluation of the stability, in different relative humidities, of hot melted acetaminophen extrudates for 3D printin | Gabriela Pereira | ![]() |
![]() |
|||
POSBAS-041 | Mechanisms of activity loss for a multi-PEGylated protein by experiment and simulation | Ahlem Zaghmi | ![]() |
![]() |
|||
PSWCS-041 | Organs-on-Chips: A platform for drug development and disease modeling | Daniel Levner | ![]() |
![]() |
|||
PSWCS-042 | Framework to Define Pharmaceutical Supply Chain Vulnerability | Michael Levy | ![]() |
![]() |
|||
PSWCS-043 | Implementation of genomics in clinical care | Catalina Lopez-Correa | ![]() |
![]() |
|||
PSWCS-044 | UK Cell and Gene Therapy Catapult: A model for the world? | Nuno Madeira do O | ![]() |
![]() |
|||
PSWCS-045 | Pharmaceutical science in the development of new medicines - from concept to approval | Takashi Mano | ![]() |
![]() |
|||
PSWCS-046 | Tackling antimicrobial resistance through behaviour change approaches | Ayodeji Matuluko | ![]() |
![]() |
|||
PSWCS-047 | Modification of the gut microbiota with a prebiotic enhances Immune Checkpoint blockers anti-cancer activity | Meriem Messaoudene | ![]() |
![]() |
|||
PSWCS-048 | QSP modeling from population to patient-level predictions in immunotherapy | Oleg Milberg | ![]() |
![]() |
|||
PSWCS-049 | How COVID-19 Changedthe Future of Drug R&D? | Bernard Munos | ![]() |
![]() |
|||
PSWCS-050 | New insights from uncultivated genomes of the global human gut microbiome | Stephen Nayfach | ![]() |
![]() |
|||
PSWCS-051 | Towards stratified medicine approaches using nano-technology-based drug delivery systems: A focus on infectious diseases | Andrew Owen | ![]() |
![]() |
|||
PSWCS-052 | Targeting Intracellular Protein-Protein Interactions with Macrocyclic Peptides | Dehua Pei | ![]() |
![]() |
|||
PSWCS-053 | Evaluation of Iron Species in Healthy Subjects Treated with Generic and Reference Sodium Ferric Gluconate | James Polli | ![]() |
![]() |
|||
PSWCS-054 | 3D printing in oral dosage | Julian Quodbach | ![]() |
![]() |
|||
PSWCS-055 | Towards digital pharmaceutical care | Claudia Rijcken | ![]() |
![]() |
|||
PSWCS-056 | How translational sciences are harnessed to face COVID-19 | Joni Rutter | ![]() |
![]() |
|||
PSWCS-057 | 3D Printing of Gene Activated Matrices for Bone Tissue Engineering | Aliasger Salem | ![]() |
![]() |
|||
PSWCS-059 | Significance - developed large scale docking en route towards the first billion-compound virtual library | Brian Shoichet | ![]() |
![]() |
|||
PSWCS-061 | Delivering nanomedicines to the upper and lower airways | Fabio Sonvico | ![]() |
![]() |
|||
PSWCS-062 | Dicloxacillin in drug-drug interactions a translational tale from registries to the bench and back again | Tore B. Stage | ![]() |
![]() |
|||
PSWCS-065 | Balancing basic and clinical pharmaceutical science in a pharmacy degree | Craig Svensson | ![]() |
![]() |
|||
PSWCS-066 | Pharmacogenomics and pharmacotherapy of common diseases: prescribing the right drug at the right dosage for the right person | Jean-Claude Tardif | ![]() |
![]() |
|||
PSWCS-068 | Impacts of large scale adoption of genomics in a health-care system | Jacques Turgeon | ![]() |
![]() |
|||
PSWCS-071 | Roles of Systems Pharmacology in Developing Personalized Cancer Treatment Regimens | Paolo Vicini | ![]() |
![]() |
|||
PSWCS-073 | Opportunities and barriers of joint approaches to enhance causal inference on drug effects | Almut Winterstein | ![]() |
![]() |
|||
PSWCS-075 | Privacy Preserving Artificial Intelligence for Tx Selection | Alexandre LeBouthillier | ![]() |
![]() |
|||
PSWCS-077 | Potential of AI in predicting translational success of drug candidates through clinical research | Massimo Riccaboni | ![]() |
![]() |
|||
PSWCS-078 | Oral Presentation | Elias Gedamu | ![]() |
![]() |
|||
PSWCS-079 | Oral Presentation | Rodi Abdalkader | ![]() |
![]() |
|||
PSWCS-083 | Oral Presentation | Sven Ansorge | ![]() |
![]() |
|||
PSWCS-085 | Oral Presentation | Man Zawati | ![]() |
![]() |
|||
PSWCS-088 | Oral Presentation | Fouad Atouf | ![]() |
![]() |
|||
PSWCS-089 | Oral Presentation | Steven Keizer | ![]() |
![]() |
|||
PSWCS-090 | Tacking medication price hike: A case for patent-free drugs | Serge Afeli | ![]() |
![]() |
|||
PSWCS-091 | Oral Presentation | Frank Gupton | ![]() |
![]() |
|||
PSWCSUB-922 | Paper-Based Diagnostic Devices for Monitoring Drug Therapy: Focus on Anticoagulation | Daniel Zaldumbide | ![]() |
![]() |
October 4-6, 2020 Virtual Conference
![]() |
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. ![]() To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. ![]() |
![]() |
||
![]() |
|